2023 marks five years of industry-leading DRAGEN software offered by Illumina SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN™ software for analysis of next-generation sequencing data. DRAGEN 4.2 expands award-winning accuracy combined with its renowned flexibility and scalability to [...]

First-of-its-kind screening kit now available for AAV8 – along with a suite of high-quality reagents to support the entire AAV workflow – helping gene therapy developers save months in process development HOLLISTER, Calif. -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the research, discovery, development, and commercialization of novel [...]

Piscataway, NJ – Sampled1 today announced that it has been named a Certified Service Provider for PacBio, a leading developer of high-quality, highly accurate sequencing solutions, equipping Sampled to deliver the highest quality advanced sequencing technology services on PacBio’s technology. To achieve this certification, providers must undergo a rigorous process including training on PacBio sample processing [...]

Global laboratory informatics leader launches discipline-specific solutions unified by Clinisys Platform™ SaaS architecture and data model Tucson, AZ - Clinisys today announced it has launched Clinisys Laboratory Solutions™, with four enhanced solutions spanning the Clinisys Environmental Laboratory™, Clinisys Water Quality Laboratory™, Clinical Toxicology Laboratory™, and Clinisys Public Health Laboratory™. Clinisys Laboratory Solutions are discipline-specific laboratory [...]

Austin, Texas – L7 Informatics, Inc, the leading provider of scientific solutions for research, development, manufacturing, and quality control, is delighted to announce the expansion of its European operations, reinforcing its dedication to serving the pharmaceutical and biotech industries with advanced capabilities. This strategic move emphasizes L7’s commitment to delivering unparalleled support and innovation to [...]

Appointment bolsters executive leadership team and adds exceptional single cell applications and product development expertise to the organization. SAN DIEGO, Calif. and CAMBRIDGE, UK - CS Genetics, a privately held genomics-technology company, today announced the appointment of Mike Stubbington, PhD, as Vice President of Research and Development. Mike joins CS Genetics with a decade of experience [...]

10x and Harvard now must defend against allegations that they “are pursuing an ill-gotten monopoly by enforcing patents that are subject to a requirement that they be licensed non-exclusively” SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United [...]

A powerful solution for PCR sample management in molecular diagnostics The Mirage 2D barcode reader from Ziath has been optimized for reading Individual Access 2D coded PCR plates from 4titude, both part of Azenta Life Sciences, Burlington, MA. The Individual Access PCR plate is part of the acclaimed Framestar range from 4titude which combines the [...]

10x and President and Fellows of Harvard ordered to answer counterclaims asserted by Vizgen CAMBRIDGE, Mass. – Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today noted the order on Vizgen’s counterclaims against Plaintiffs 10x Genomics, Inc. (“10x”) and Harvard College (“Harvard”) [...]

SEATTLE -- Pluristyx, Inc. today announced an agreement with the Advanced Regenerative Manufacturing Institute | BioFabUSA to manufacture and commercialize Pluristyx’s clinical-grade reprogrammed induced Pluripotent Stem Cells (iPSCs). This collaboration will make it possible to accelerate the scalable, consistent, and cost-effective manufacturing of stem cell derived products for patient administration. The agreement provides ARMI | [...]